-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Alignment Healthcare, Lowers Price Target to $9

Benzinga·10/12/2026 21:13:03
Diffusion vocale
UBS analyst Jonathan Yong maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and lowers the price target from $22 to $9.